1)Tachimori Y, et al:Comprehensive registry of esophageal cancer in Japan, 2009. Esophagus 13:110-137, 2016
2)Hironaka S, et al:Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2-3)N(any)M(0)squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 57:425-433, 2003
3)Kato K, et al:Phase Ⅱ study of chemoradiotherapy with 5-fluorouracil and cisplatic for Stage Ⅱ-Ⅲ esophageal squamous cell carcinoma:JCOG trial(JCOG9906). Int J Radiat Oncol Biol Phys 81:684-690, 2011
4)Ishikura S, et al:Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol 21:2697-2702, 2003
5)Nishimura M, et al:Salvage esophagectomy following definitive chemoradiotherapy. Gen Thorac Cardiovasc Surg 55:461-464, 2007
6)Tachimori Y, et al:Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg 137:49-54, 2009
7)Miyata H, et al:Salvage esophagectomy after definitive chemoradiotherapy for thoracic esophageal cancer. J Surg Oncol 100:442-446, 2009
8)Morita M, et al:Clinical significance of salvage esophagectomy for remnant or recurrent cancer following definitive chemoradiotherapy. J Gastroenterol 46:1284-1291, 2011
9)Yano T, et al:Long-term results of salvage endoscopic mucosal resection in patients with local failure after definitive chemoradiotherapy for esophageal squamous cell carcinoma. Endoscopy 40:717-721, 2008
10)McMahon KS, et al:Effects of photodynamic therapy using mono-L-aspartyl chlorin e6 on vessel constriction, vessel leakage, and tumor response. Cancer Res 54:5374-5379, 1994
11)Gollnick SO, et al:Role of cytokines in photodynamic therapy-induced local and systemic inflammation. Br J Cancer 88:1772-1779, 2003
12)Dougherty TJ, et al:Photoradiation therapy for the treatment of malignant tumors. Cancer Res 38:2628-2635, 1978
13)Yano T, et al:Long-term results of salvage photodynamic therapy for patients with local failure after chemoradiotherapy for esophageal squamous cell carcinoma. Endoscopy 43:657-663, 2011
14)Ohashi S, et al:Preclinical validation of talaporfin sodium-mediated photodynamic therapy for esophageal squamous cell carcinoma. PLoS One 9:e103126, 2014
15)Horimatsu T, et al:Tissue damage in the canine normal esophagus by photoactivation with talaporfin sodium(laserphyrin):a preclinical study. PloS One 7:e38308, 2012
16)Yano T, et al:Phase Ⅰ study of photodynamic therapy using talaporfin sodium and diode laser for local failure after chemoradiotherapy for esophageal cancer. Radiat Oncol 7:113, 2012
17)Yano T, et al:A multicenter phase Ⅱ study of salvage photodynamic therapy using talaporfin sodium(ME2906)and a diode lase(PNL6405EPG)for local failure after chemoradiotherapy or radiotherapy for esophageal cancer. Oncotarget 8:22135-22144, 2017
18)Yamamoto S, et al:Endoscopic classification of local recurrence after definitive chemoradiotherapy for esophageal squamous cell carcinoma. Esophagus 6:243, 2009
19)Tu CH, et al:Submucosal tumor appearance is a useful endoscopic predictor of early primary-site recurrence after definitive chemoradiotherapy for esophageal squamous cell carcinoma. Dis Esophagus 24:274-278, 2011